Abstract:Introduction: Numerous studies on hematopoietic changes caused by HIV infection have focused on immune cell depletion, while research on other hematopoietic lineages development have been sparse and inconclusive. In this study, we used precise markers to detect changes in the distribution of bone marrow hematopoietic stem/progenitor cells in HIV-infected patients and analyzed the dynamic changes of mature cells of each lineages in 782 patients with disease progression. Furthermore, we sought to explore the potential relationship between abnormal development of these lineage cells and survival of HIV patients. Our study provides evidence for a more comprehensive understanding of the effects of HIV on hematopoiesis. Methods: We included 782 HIV-infected patients who underwent bone marrow aspiration from January 2016 to October 2020 in Zhongnan Hospital, and were followed up until January 2022. Examination including flow cytometry and bone marrow aspiration were performed to detect the development of hematopoietic cells. 509 cases were tested for lymphocyte subsets. According to CD3+CD4+ cell count, 325 patients (63.9%) were in the very low group, 61 patients (12.0%) in the low group, 55 patients (10.8%) in the medium group, and 68 patients (13.4%) in the high group. By January 2022, 84 patients had been lost to follow-up and 425 patients had accurate and complete follow-up data. We analyzed the risk factors for HIV death in 425 patients and established a predictive model. Results: Flow cytometry analysis showed an increased proportion of granulocytemonocyte progenitors (GMP) but a decreased proportion of common lymphoid progenitors (CLP) in HIV patients. In myelogram, the percentage of granulocytes and granulocytes/erythroid cells (G/E) increased with the decrease of CD3+CD4+ count (both P<0.001). In addition to the increase in cell proportion, we also observed that the morphologic abnormalities in granulocyte increased with the progression of the disease, including toxic granulation, cytoplasmic vacuolization, Intracellular and extracellular plasma (P<0.001), Döhle bodies (P=0.033) and increased lobulation in megakaryocyte (P=0.048). Subsequent LASSO binary logistic regression also confirmed that the increased granulocyte ratio was an important factor in patients' disease. Conclusion: HIV infection directly or indirectly induces bias on myeloid lineage differentiation. Increased granulocyte ratio is an important risk factor for disease aggravation and death in HIV patients. Our research provide a new perspective for evaluating the status and prognosis of HIV patients by focusing on the changes of myeloid granulocytes. Disclosures No relevant conflicts of interest to declare.

HIV-1 Infection Depletes Human CD34+CD38- Hematopoietic Progenitor Cells Via Pdc-Dependent Mechanisms

Plasmacytoid Dendritic Cells Suppress Hiv-1 Replication but Contribute to Hiv-1 Induced Immunopathogenesis in Humanized Mice

Plasmacytoid Dendritic Cells Impair HIV-specific CD8 T Cells to Maintain HIV-1 Reservoir Persistence During Chronic HIV Infection under Cart

HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors.

Plasmacytoid Dendritic Cells Prime Antiviral T Cells During Acute Hiv-1 Infection But Deplete And Impair Anti-Viral T Cells During Chronic Hiv-1 Infection

Targeting c-Mpl for Revival of Human Immunodeficiency Virus Type 1-Induced Hematopoietic Inhibition When CD34+ Progenitor Cells Are Re-Engrafted into a Fresh Stromal Microenvironment In Vivo

HIV Infection Induces Aberrant Myeloid Lineage Differentiation

Plasmacytoid Dendritic Cells Contribute to HIV Diseases and Viral Persistence Via IDO-dependent Mechanisms

Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma.

Plasmacytoid Dendritic Cells Impair Anti-HIV Immunity and HIV-1 Persistence During Antiretroviral Therapy Via IDO-Dependent Mechanisms

Expansion of Monocytic Myeloid-Derived Suppressor Cells Dampens T Cell Function in HIV-1-Seropositive Individuals

Chinese Human Immunodeficiency Virus-1 Patients with Different Routes of Transmission Exhibit Altered Expression Levels of Blood Dendritic Cell Subpopulations

Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-infected Children after Treatment with Highly Active Antiretroviral Therapy.

Chronic Hiv-1 Infection Induces the Depletion and Functional Impairment of Group-3 Innate Lymphoid Cells Through Plasmacytoid Dendritic Cells and Type I Interferon

B7-H1 Up-Regulation Impairs Myeloid Dc and Correlates with Disease Progression in Chronic Hiv-1 Infection

Polymorphonuclear myeloid-derived suppressor cells regulates immune recovery during HIV infection through PD-L1 and TGF-β pathways

CD56dim NK Cell is an Important Factor in T Cell Depletion of Cart-Treated AIDS Patients

Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction

Infection and Depletion of CD4+ Group-1 Innate Lymphoid Cells by HIV-1 Via Type-I Interferon Pathway.

Clinical Significance of Myeloid‐Derived Suppressor Cells in Human Immunodeficiency Virus‐1/ Hepatitis C Virus‐coinfected Patients

Analysis of B cell phenotype and the restoration of antiretroviral therapy in chronic human immunodeficiency virus type 1 infection